Krystal Biotech, Inc.
KRYS
$193.84
-$6.13-3.07%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 1.83% | 8.91% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 1.83% | 8.91% | |||
| Cost of Revenue | -40.50% | 42.50% | |||
| Gross Profit | 5.24% | 6.88% | |||
| SG&A Expenses | 6.88% | 7.45% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -0.54% | 9.09% | |||
| Operating Income | 5.26% | 8.65% | |||
| Income Before Tax | 2.55% | 7.29% | |||
| Income Tax Expenses | -471.93% | 7.35% | |||
| Earnings from Continuing Operations | 107.04% | 7.28% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 107.04% | 7.28% | |||
| EBIT | 5.26% | 8.65% | |||
| EBITDA | 5.19% | 8.19% | |||
| EPS Basic | 106.74% | 6.92% | |||
| Normalized Basic EPS | 2.39% | 6.94% | |||
| EPS Diluted | 106.20% | 7.50% | |||
| Normalized Diluted EPS | 2.26% | 7.73% | |||
| Average Basic Shares Outstanding | 0.15% | 0.33% | |||
| Average Diluted Shares Outstanding | 0.28% | -0.41% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||